Method of prophylaxis or treatment of antigen presenting...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 38/17 (2006.01) A61P 17/00 (2006.01) C12P 21/08 (2006.01)

Patent

CA 2120732

Methods of using inhibitors of the CD2/LFA-3 interaction in treating skin conditions characterized by increased T cell activation and abnormal antigen presentation in the dermis and epidermis in mammals, including humans. Sugh conditions include psoriasis, UV damage, atopic dermatitis, cutaneous T cell lymphoma such as mycosis fungoides, allergic and irritant contact dermatitis, lichen planus, alopecia areata, pyoderma gangrenosum, vitiligo, ocular cicatricial pemphigoid, and urticaria.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method of prophylaxis or treatment of antigen presenting... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of prophylaxis or treatment of antigen presenting..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of prophylaxis or treatment of antigen presenting... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1397413

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.